Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Multiple Myeloma 8Prostatic Neoplasms 6Neoplasms, Plasma Cell 6Sarcoma 5Neoplasms 5Melanoma 4Liver Neoplasms 4Leukemia, Lymphocytic, Chronic, B-Cell 4Carcinoma, Hepatocellular 4Lymphoma, Follicular 3Leukemia 3Carcinoma, Renal Cell 3Brain Neoplasms 3Myelodysplastic Syndromes 2Lymphoma 2Kidney Neoplasms 2HIV Infections 2Endometrial Neoplasms 2Carcinoma, Ovarian Epithelial 2Acquired Immunodeficiency Syndrome 2Waldenstrom Macroglobulinemia 1Urologic Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Stomatitis, Aphthous 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma, Endometrial Stromal 1Recurrent Uterine Corpus Sarcoma 1Rectal Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 4fludarabine phosphate 3Methotrexate 3Filgrastim 3Etoposide 3Cytarabine 3Busulfan 3sargramostim 2merphos 2Vorinostat 2Idarubicin 2Granulocyte-Macrophage Colony-Stimulating Factor 2Decitabine 2Cyclosporine 2tipifarnib 1palmitoyl-L-asparaginase 1entinostat 1bryostatin 1 1aldesleukin 1Vitamin E 1Transplantation 1Topotecan 1Thioguanine 1Thalidomide 1Tacrolimus 1Radiotherapy, Conformal 1Methylprednisolone 1Lenalidomide 1Isotretinoin 1Interleukin-2 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Anemia, Refractory × Thalidomide × Clear all
NCT00015990 2013-01-24

Thalidomide in Treating Patients With Myelodysplastic Syndrome

National Cancer Institute (NCI)

Phase 2 Completed
29 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡